FilingFirehose · free AI preview
KalVista Pharmaceuticals, Inc.
KALV · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Delisting, Officer Departure
KalVista Pharmaceuticals filed a red-flag 8-K on June 11, 2026 indicating delisting risk and an officer departure, signaling potential governance and listing status concerns. The filing touched multiple disclosure items including material agreements and officer changes, suggesting operational strain beyond the surface headlines. Our 90-day detection window captured this event, but context on the company's financing history, shareholder dilution trajectory, and AI-scored operational risk factors remains incomplete. The full $49 Report adds detailed 8-K analysis, 12-month event history, dilution scoring, and forward-looking risk signals to assess whether this is a temporary disruption or a deeper institutional problem.
Want the full 5-section $49 Report on KALV?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.